Agilent Technologies vs Bio-Techne
Agilent Technologies (A) and Bio-Techne (TECH) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $48B
- Last close
- $170.38
- 12 months
- +17.4%
- Market value
- $11.4B
- Last close
- $72.67
- 12 months
- +23.7%
At a glance
- The biggest part of Agilent Technologies's revenue is Agilent CrossLab (42%); at Bio-Techne it is Protein Sciences (72%).
- By market value, Agilent Technologies ($48.0B) is about 4.2 times Bio-Techne ($11.4B).
- Over the last 12 months Agilent Technologies's share price moved +17.4% and Bio-Techne's +23.7%; against the S&P 500 that is +11.7 points and +18.0 points.
- In their last fiscal years Agilent Technologies kept 18.8% of revenue as net income and Bio-Techne 6.0%.
- In the last 90 days insiders reported 0 open-market purchases at Agilent Technologies and 0 at Bio-Techne; members of Congress disclosed 0 trades in Agilent Technologies and 0 in Bio-Techne.
- Next results: Agilent Technologies Nov 23, 2026, Bio-Techne Feb 2, 2027.
How each one makes money: Agilent Technologies revenue · Bio-Techne revenue
Share prices on one chart
Agilent Technologies and Bio-Techne, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Agilent Technologies ANYSE · Life Sciences Tools & Services | Bio-Techne TECHNASDAQ · Life Sciences Tools & Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $48B | $11.4B |
| Revenue, last fiscal year | $6.95B | $1.22B |
| Net income, last fiscal year | $1.3B | $73.4M |
| Net marginNet income as a share of revenue | 18.8% | 6.0% |
| Free cash flow | $1.15B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Agilent Technologies against
Common questions
How is Agilent Technologies different from Bio-Techne?
Agilent Technologies (A) is in Life Sciences Tools & Services on NYSE, with $6.95B of revenue in its last fiscal year and a net margin of 18.8%. Bio-Techne (TECH) is in Life Sciences Tools & Services on NASDAQ, with $1.22B of revenue in its last fiscal year and a net margin of 6.0%. The biggest part of Agilent Technologies's revenue is Agilent CrossLab (42%); at Bio-Techne it is Protein Sciences (72%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Agilent Technologies and Bio-Techne compare in size?
Agilent Technologies has the larger market value: Agilent Technologies $48B and Bio-Techne $11.4B, at the last close.
Whose share price rose more over the last 12 months, A or TECH?
Over the last 12 months Agilent Technologies moved +17.4% and Bio-Techne +23.7%. Past price moves say nothing about the future.
Which has had more insider buying, Agilent Technologies or Bio-Techne?
Since 2006, Agilent Technologies insiders reported 16 open-market purchases against 7 for Bio-Techne. These are counts of what was filed, not a view on either stock.
Do members of Congress trade A or TECH?
In the last 12 months, members of Congress disclosed 2 trades in Agilent Technologies (A) and 6 in Bio-Techne (TECH).
When did insiders last buy A and TECH?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Agilent Technologies pageBio-Techne pageRare insider trades this weekAll comparisons
https://oqro.io/compare/a-vs-tech







